The prognosis for acute myeloid leukemia (AML) after all treatments fail varies significantly among individuals. Generally, the median survival time after treatment failure is limited, often ranging from a few weeks to several months, depending on factors such as the patient's overall health, age, and specific disease characteristics. Some patients may enter a phase of relapse or progression that can further affect survival. Palliative care can help manage symptoms and improve quality of life during this time.
Copyright © 2026 eLLeNow.com All Rights Reserved.